abstract |
(57) [Summary] The present invention provides formula (I): [Wherein R, R 1 , R 2 , R 3 , Z, A and m have the same meaning as described in the specification]. These compounds are leukotriene antagonists and as such can be used in the treatment of various diseases associated with leukotrins. |